The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 50%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (6 analysts) rates it buy, with a mean price target of $114.
Monarch Casino & Resort, Inc.
MCRI · Nasdaq · USD · Market cap $2.2B · 2,740 employees
Monarch Casino & Resort, Inc., through its subsidiaries, owns and operates hotels and casinos.
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Monarch Casino & Resort, Inc. holds its Accumulation at $121.52. Consolidating, no directional conviction, held for 5 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 5 days |
| Price at the screen | $121.52 |
| Valuation | 19.51 trailing · 17.62 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.34 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: casino
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: casino | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. The price runs 4.1% above the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits +4% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCasinos tempt with steady returns but ethics block the door
Step into a Reno casino on a busy weekend and the chips clatter while the slots ring. Monarch runs two solid properties and posts a 20% profit margin with 9% revenue growth. Yet the ethical screen flags the whole sector as off-limits, so the numbers never get a proper look in.
The shares trade at 17.5 times forward earnings with almost no margin of safety to our fair value. Analyst targets sit below the current price and the opportunity rating is none. Strong returns on equity do not change the fact that we simply do not engage once the screen has spoken.
Cyclical demand can swing hard when travel slows or regulation tightens. Currency and local competition add further uncertainty on top of the ethical bar. Analysis, not advice.
| Forward P/E | 17.6xexpensive even after accounting for its growth |
| Trailing P/E | 19.5xreasonably valued |
| EPS, trailing | 6.23 |
| EPS, forward | 6.90 |
| Revenue growth | +4.2%slow but positive growth |
| Profit margin | 20.4%healthy profit margins |
| Return on equity | 20.5%an exceptional return on shareholder capital |
| FCF yield | 6.06% |
| Dividend yield | 93.00% |
| Debt to equity | 2.22heavy leverage: higher risk if revenue softens |
| Current ratio | 1.21adequate liquidity, worth monitoring |
| Beta | 1.34moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 88.13 - 135.93 |
| Market cap | $2.2B |
| Employees | 2,740 |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMCRI trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 50%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (6 analysts) rates it buy, with a mean price target of $114.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 50%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (6 analysts) rates it buy, with a mean price target of $114.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $116.75 | +8.9% | $0.30 | $1,092 | +9.2% |
| 2 months | $98.08 | +29.6% | $0.30 | $1,299 | +29.9% |
| 3 months | $99.41 | +27.9% | $0.30 | $1,282 | +28.2% |
| 6 months | $97.84 | +30.0% | $0.60 | $1,306 | +30.6% |
| 1 year | $84.52 | +50.4% | $1.20 | $1,518 | +51.8% |
| 2 years | $65.36 | +94.5% | $2.40 | $1,982 | +98.2% |
| 3 years | $65.98 | +92.7% | $3.60 | $1,982 | +98.2% |
| 5 years | $63.76 | +99.4% | $8.90 | $2,134 | +113.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MCRI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.